Search results
Showing results for
The UK regulator MHRA announced on 26 June that it would again permit recruitment to the COPCOV COVID-19 prevention clinical trial. The MHRA decision came 5 weeks after it reacted immediately to the now-discredited paper published in The Lancet suggesting harms with hydroxychloroquine, and paused recruitment of UK participants. But The Lancet paper was based on fabricated data and was swiftly retracted. After this interruption, recruitment around the globe to COPCOV can now resume.
©
2020 MORU. Photographer: Supa-at Asarath.
Interrupted time-series analysis of nationwide surveillance in Thai adult pneumococcal diseases over 14 years: evidence to inform policy in resource-limited countries
Journal article
Ngamprasertchai T. et al, (2026), Expert Review of Vaccines, 25
Community and stakeholder engagement in national priority setting and participatory research for HIV, Tuberculosis, and Malaria programs in Nepal
Journal article
Neupane S. et al, (2026), Research Involvement and Engagement, 12
Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025
Journal article
Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766
A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam
Journal article
Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections: a secondary analysis of observational data
Journal article
Hagedoorn NN. et al, (2026), Vaccine, 85, 128691 - 128691
Cross- Wellcome Africa Asian Programmes (AAPs) Acceleration of Genomics for Escalating infectious Diseases, (CAGED) Consortium
Journal article
Kiyuka PK. et al, (2026), Wellcome Open Research, 11, 87 - 87
Mortality and Length of Stay Associated With Community-Acquired Escherichia coli and Staphylococcus aureus Bloodstream Infections: An Observational Study in 9 Low- and Middle-Income Countries
Journal article
Hopkins J. et al, (2026), Clinical Infectious Diseases
Comparison of in vitro antibiotic susceptibility testing of R. typhi using plaque assay and quantitative real-time PCR
Journal article
Phuklia W. et al, (2026), Microbiology Spectrum, 14
Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines
Journal article
Arman BY. et al, (2026), International Journal of Pharmaceutics: X, 11, 100467 - 100467
Assessing transporter‐mediated rifampin–linezolid interaction using physiologically‐based pharmacokinetic modelling
Journal article
Nguyen HD. et al, (2026), British Journal of Clinical Pharmacology, 92, 1845 - 1856
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial
Journal article
Degaga TS. et al, (2026), The Lancet Infectious Diseases, 26, 614 - 626
Population pharmacokinetics of lumefantrine in pregnant and non-pregnant Nigerian women receiving efavirenz-based antiretroviral therapy.
Journal article
Akinrinade TO. et al, (2026), European journal of clinical pharmacology, 82
Rickettsial seropositivity in Lao PDR smallholder livestock farms: Implications for animal and human health.
Journal article
Tawfik C. et al, (2026), One health (Amsterdam, Netherlands), 22
Efficacy and Safety of Newer Antibiotics Versus Generic Antibiotics for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Journal article
Nguyen ATK. et al, (2026), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 82, S116 - S125
Challenges to Accessing Newer Antibiotics for Multidrug-resistant Bacterial Infections in Asia: A Literature Review of Multi-Stakeholder Perspectives.
Journal article
Aligui AF. et al, (2026), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 82, S154 - S161
Using oral and parenteral formulation of AWaRe antibiotics as a proxy estimate of community and hospital healthcare sector use.
Journal article
Lim C. et al, (2026), JAC-antimicrobial resistance, 8
Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.
Journal article
Manesh A. et al, (2026), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 82, S105 - S115
Neglected rickettsial diseases in Southeast Asia: Twenty-five years of progress in surveillance, diagnostics, and clinical research
Journal article
Blacksell SD. et al, (2026), PLOS Neglected Tropical Diseases, 20, e0014318 - e0014318
Mapping the global distribution and spread of the Plasmodium vivax -associated virus MaRNAV-1
Journal article
Petrone ME. et al, (2026), Virus Evolution
Engagement with communities at-risk of scrub typhus: lessons learned from Northen Thailand
Preprint
Perrone C. et al, (2026)